Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08LQD
|
||||
Former ID |
DIB002843
|
||||
Drug Name |
RESEQUINIL
|
||||
Synonyms |
AVE-3933; SX-3933; Resequinil < Prop INN >; 5-(3-Methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-1,6-naphthyridin-2(1H)-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Epilepsy [ICD10:G40] | Discontinued in Phase 2 | [546863] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H14N4O3
|
||||
Canonical SMILES |
COc1cccc(c1)c2nccc3NC(=O)C(=Cc23)c4noc(C)n4
|
||||
InChI |
1S/C18H14N4O3/c1-10-20-17(22-25-10)14-9-13-15(21-18(14)23)6-7-19-16(13)11-4-3-5-12(8-11)24-2/h3-9H,1-2H3,(H,21,23)
|
||||
InChIKey |
JQOFKKWHXGQABB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | GABA A receptor | Target Info | Agonist | [550144] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.